CGS 5649 B, a new compound, reverses age-related cognitive dysfunctions in rats

This publication has 17 references indexed in Scilit:

• Drug Treatment of Alzheimer's Disease
  Archives of internal medicine (1960), 1991
• The effect of long‐term physostigmine administration in Alzheimer's disease
  Neurology, 1990
• Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study
  American Journal of Psychiatry, 1990
• Drug treatments for cognitive impairment due to ageing and disease: Current and future strategies
  International Journal of Geriatric Psychiatry, 1989
• Do piracetam-like compounds act centrally via peripheral mechanisms?
  Brain Research, 1987
• Enhancing effects of Hoe 175 on memory in mice
  Psychopharmacology, 1985
• Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents
  Psychopharmacology, 1982
• Oral Administration of Chronic Physostigmine does not Improve Cognitive or Mnesic Performances in Alzheimer's Presenile Dementia
  International Journal of Neuroscience, 1982
• Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine
  Pharmacology Biochemistry and Behavior, 1978
• A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
  Biometrika, 1965